An antibacterial peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Pap12-6 (trifluoroacetate salt)

Item No. 37454

Technical Information
Formal Name
(S)-N-((2S,5S,8S,11S,14S,17S)-2-((1H-indol-3-yl)methyl)-1,21-diamino-5,8-bis(4-aminobutyl)-11,14-diisopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazahenicosan-17-yl)-2-((6S,9S,12S,15S,18S)-9-((1H-indol-3-yl)methyl)-1,6-diamino-12-(4-aminobutyl)-18-benzyl-15-((S)-sec-butyl)-1-imino-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecan-19-amido)-6-aminohexanamide, trifluoroacetate salt
Molecular Formula
C83H133N23O12 • XCF3COOH
Formula Weight
Purity
≥95%
A solid
Peptide Sequence
RWKIFKKVVKKW-NH2
Water: soluble
SMILES
OC(C(F)(F)F)=O.O=C([C@@H](N)CCCNC(N)=N)N[C@H](C(N[C@H](C(N[C@@]([H])([C@H](CC)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CC2=CNC3=C2C=CC=C3)=O)CCCCN)=O)CCCCN[H])=O)C(C)C)=O)C(C)C)=O)CCCCN)=O)CCCCN)=O)=O)=O)CCCCN)=O)CC4=CNC5=C4C=CC=C5
InChi Code
InChI=1S/C83H133N23O12.C2HF3O2/c1-7-51(6)70(106-77(113)64(37-19-24-42-88)99-79(115)67(46-54-48-95-59-32-14-12-29-56(54)59)102-72(108)57(89)30-25-43-93-83(91)92)82(118)103-66(44-52-26-9-8-10-27-52)78(114)98-60(33-15-20-38-84)73(109)97-63(36-18-23-41-87)76(112)104-69(50(4)5)81(117)105-68(49(2)3)80(116)100-62(35-17-22-40-86)74(110)96-61(34-16-21-39-85)75(111)101-65(71(90)107)45-53-47-94-58-31-13-11-28-55(53)58;3-2(4,5)1(6)7/h8-14,26-29,31-32,47-51,57,60-70,94-95H,7,15-25,30,33-46,84-89H2,1-6H3,(H2,90,107)(H,96,110)(H,97,109)(H,98,114)(H,99,115)(H,100,116)(H,101,111)(H,102,108)(H,103,118)(H,104,112)(H,105,117)(H,106,113)(H4,91,92,93);(H,6,7)/t51-,57-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-;/m0./s1
InChi Key
BSFQJZVVHORVRL-HSQLCMMYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Pap12-6 is an antibacterial peptide derived from the twelve N-terminal amino acids of the peptide papiliocin, which has been found in P. xuthus larvae.1 It is active against a panel of eight Gram-negative bacteria, including E. coli, P. aeruginosa, and S. syphimurium (MIC50s = 4-8 µM), and the Gram-positive bacteria S. aureus, methicillin-resistant S. aureus 3126 (MRSA-3126), B. subtilis, and S. epidermidis (MIC50s = 4-8 µM) without affecting the viability of human erythrocytes, mouse RAW 264.7 macrophages, human HaCaT keratinocytes, or human HEK293 kidney cells at 25 µM. Pap12-6 induces membrane depolarization in E. coli when used at concentrations of 4 and 8 µM. Preincubation with Pap12-6 (10 µM) reduces nitrite (NO2-), Tnf-α, and Il-6 secretion levels in LPS-stimulated RAW 264.7 macrophages. In vivo, Pap12-6 (10 mg/kg) increases survival in mice infected with E. coli, as well as reduces the number of colony forming units (CFUs) in the lungs, liver, and kidneys in E. coli-infected mice when administered at a dose of 1 mg/kg. Pap12-6 (1 mg/kg) reduces serum aspartate aminotransferase (AST) and alanine transaminase (ALT) levels and blood urea nitrogen levels in a mouse model of E. coli-induced sepsis.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kim, J., Jacob, B., Jang, M., et alDevelopment of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis. Sci. Rep. 9(1), 3817 (2019).